ANALYSIS OF THE FLT3-ITO AND NPM1 MUTATIONS IN AML PATIENTS WITH INTERMEDIATE RISK RECEIVING ALLOGENEIC STEM-CELL TRANSPLANTATION

被引：0
|
作者：
Ogasawara, M. [1 ]
Yamakawa, T. [1 ]
Katsura, Y. [1 ]
Shima, K. [1 ]
Matsukawa, T. [1 ]
Kanaya, M. [1 ]
Minauchi, K. [1 ]
Nakata, M. [1 ]
Ota, S. [1 ]
Imai, K. [1 ]
Hirano, T. [1 ]
Kobayashi, N. [1 ]
Kiyama, Y. [1 ]
机构：
[1] Sapporo Hokuyu Hosp, Sapporo, Hokkaido, Japan
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.432
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
396
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [31] Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML
    Pasic, Ivan
    Da'na, Waleed
    Lam, Wilson
    Law, Arjun
    Lipton, Jeffrey H.
    Viswabandya, Auro
    Kim, Dennis D.
    Thyagu, Santhosh
    Messner, Hans A.
    Michelis, Fotios V.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (04) : 368 - 374
  • [32] Detection of relapse following allogeneic stem cell transplantation in AML:: NPM1-mutations precede the FLT3-LM/ITD and changes in chimerism
    Bacher, U.
    Badbaran, A.
    Fehse, B.
    Zabelina, T.
    Zander, A. R.
    Kroeger, N.
    ANNALS OF HEMATOLOGY, 2008, 87 : S4 - S4
  • [33] THE ROLE OF ALLOGENEIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH NPM1 ACUTE MYELOID LEUKEMIA
    Lussana, F.
    Caprioli, C.
    Stefanoni, P.
    Pavoni, C.
    Spinelli, O.
    Michelato, A.
    Buklijas, K.
    Algarotti, A.
    Mico, C.
    Grassi, A.
    Intermesoli, T.
    Rambaldi, A.
    HAEMATOLOGICA, 2019, 104 : 20 - 20
  • [34] Acute Myeloid Leukemia (AML) with Type A NPM1 Mutation Is More Frequently Associated with FLT3 Mutations Compared with AML with Non-Type A NPM1 Mutations
    Kanagal-Shamanna, R.
    Singh, R. R.
    Routbort, M. J.
    Ravandi, F.
    Kantarjion, H.
    Medeiros, L. J.
    Luthra, R.
    Patel, K. P.
    MODERN PATHOLOGY, 2014, 27 : 354A - 354A
  • [35] The Impact of DNMT3A/FLT3-ITD/NPM1 on Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    Su, Long
    TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 (01) : 64 - 64
  • [36] Acute Myeloid Leukemia (AML) with Type A NPM1 Mutation Is More Frequently Associated with FLT3 Mutations Compared with AML with Non-Type A NPM1 Mutations
    Kanagal-Shamanna, R.
    Singh, R. R.
    Routbort, M. J.
    Ravandi, F.
    Kantarjian, H.
    Medeiros, L. J.
    Luthra, R.
    Patel, K. P.
    LABORATORY INVESTIGATION, 2014, 94 : 354A - 354A
  • [37] Allogeneic Stem Cell Transplantation For Cytogenetically Normal Acute Myeloid Leukemia: Impact Of FLT3 and NPM1 Mutational Status
    Hemmati, Philipp
    Terwey, Theis H.
    Vuong, Lam G.
    le Coutre, Philipp D.
    Doerken, Bernd
    Arnold, Renate
    BLOOD, 2013, 122 (21)
  • [38] Hematologic and not molecular CR determines survival after allogeneic hematopoietic stem cell transplantation in NPM1 mutated AML
    Fraccaroli, A.
    Stauffer, E.
    Koch, K.
    Hirschbuehl, K.
    Breitkopf, S.
    Drolle, H.
    Rothenberg-Thurley, M.
    Dufour, A.
    Metzeler, K.
    Spiekermann, K.
    Hausmann, A.
    Schmid, C.
    Verbeek, M.
    Herold, T.
    Tischer, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 134 - 135
  • [39] Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AML
    Zhou, Yi
    Othus, Megan
    Walter, Roland B.
    Estey, Elihu H.
    Wu, David
    Wood, Brent L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (08) : 1615 - 1620
  • [40] Impact of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation
    Khanolkar, Rutvij A.
    Faridi, Rehan M.
    Kinzel, Megan
    Jamani, Kareem
    Savoie, Mary L.
    Shafey, Mona
    Khan, Faisal M.
    Storek, Jan
    CYTOTHERAPY, 2022, 24 (04) : 413 - 420
12345